Literature DB >> 16105760

X-linked lymphoproliferative disease in an adult.

Takumi Hoshino1, Hirokazu Kanegane, Noriko Doki, Hiroyuki Irisawa, Tohru Sakura, Yoshihisa Nojima, Shuichi Miyawaki, Toshio Miyawaki.   

Abstract

X-linked lymphoproliferative disease (XLP) is an inherited immunodeficiency characterized by an extreme susceptibility to Epstein-Barr virus (EBV) infection. Patients with XLP mainly present with the 3 clinical manifestations of fulminant infectious mononucleosis, lymphoproliferative disorder, and dysgammaglobulinemia and in rare cases have aplastic anemia and lymphocytic vasculitis. The causative gene for XLP was identified as SH2D1A/DSHP/SLAM-associated protein (SAP) in 1998, and genetic analysis has been used for the definite diagnosis of XLP. Diagnosis for most patients occurs at ages younger than 10 years, and there are few adult patients. Here we describe a 23-year-old man with hypogammaglobulinemia and EBV-associated hemophagocytic lymphohistiocytosis and a diagnosis of XLP. In addition, the patient showed type 1 helper T-cell (Th1) skewing, as has been described in Sap knock-out mice. Th1/Th2 imbalance in humans, as well as in mice, may play an important role in the pathogenesis of XLP.

Entities:  

Mesh:

Year:  2005        PMID: 16105760     DOI: 10.1532/IJH97.05020

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  SAP controls T cell responses to virus and terminal differentiation of TH2 cells.

Authors:  C Wu; K B Nguyen; G C Pien; N Wang; C Gullo; D Howie; M R Sosa; M J Edwards; P Borrow; A R Satoskar; A H Sharpe; C A Biron; C Terhorst
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

2.  Regulation of NKT cell development by SAP, the protein defective in XLP.

Authors:  Kim E Nichols; Jamie Hom; Shun-You Gong; Arupa Ganguly; Cindy S Ma; Jennifer L Cannons; Stuart G Tangye; Pamela L Schwartzberg; Gary A Koretzky; Paul L Stein
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

3.  Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP.

Authors:  S G Tangye; S Lazetic; E Woollatt; G R Sutherland; L L Lanier; J H Phillips
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

4.  X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.

Authors:  Hirokazu Kanegane; Yoshikiyo Ito; Koichi Ohshima; Takeshi Shichijo; Kunio Tomimasu; Keiko Nomura; Takeshi Futatani; Ryo Sumazaki; Toshio Miyawaki
Journal:  Am J Hematol       Date:  2005-02       Impact factor: 10.047

5.  Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.

Authors:  J Sayós; M Martín; A Chen; M Simarro; D Howie; M Morra; P Engel; C Terhorst
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

6.  Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy.

Authors:  Michael C Milone; Donald E Tsai; Richard L Hodinka; Lewis B Silverman; Alejandro Malbran; Mariusz A Wasik; Kim E Nichols
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

7.  Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.

Authors:  N Yasuda; P K Lai; J Rogers; D T Purtlo
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

8.  Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection.

Authors:  Alejandro Malbran; Liliana Belmonte; Beatriz Ruibal-Ares; Patricia Baré; Ivana Massud; Cecilia Parodi; Marta Felippo; Richard Hodinka; Kathleen Haines; Kim E Nichols; María M de Bracco
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

9.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.

Authors:  A J Coffey; R A Brooksbank; O Brandau; T Oohashi; G R Howell; J M Bye; A P Cahn; J Durham; P Heath; P Wray; R Pavitt; J Wilkinson; M Leversha; E Huckle; C J Shaw-Smith; A Dunham; S Rhodes; V Schuster; G Porta; L Yin; P Serafini; B Sylla; M Zollo; B Franco; A Bolino; M Seri; A Lanyi; J R Davis; D Webster; A Harris; G Lenoir; G de St Basile; A Jones; B H Behloradsky; H Achatz; J Murken; R Fassler; J Sumegi; G Romeo; M Vaudin; M T Ross; A Meindl; D R Bentley
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

10.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.

Authors:  C Bottino; M Falco; S Parolini; E Marcenaro; R Augugliaro; S Sivori; E Landi; R Biassoni; L D Notarangelo; L Moretta; A Moretta
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

View more
  1 in total

1.  Acute Epstein-Barr virus infection presenting as severe gastroenteritis without infectious mononucleosis-like manifestations.

Authors:  Mikio Fujiwara; Shin'ichi Miyamoto; Kouta Iguchi; Toshihiro Matsunaka; Hiromi Sakashita; Tatsuaki Tsuruyama; Hirokazu Kanegane; Hiroyuki Marusawa; Hiroshi Nakase; Tsutomu Chiba
Journal:  Clin J Gastroenterol       Date:  2009-10-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.